Concurrent chemoradiotherapy with cyclophosphamide, pirarubicin, and cisplatin for patients with locally advanced salivary gland carcinoma

Acta Oto-Laryngologica

Volumn 126, Issue 12, 2006, Pages 1309-1314

  Katori, Hideaki ^a,b   Tsukuda, Mamoru ^c  

^a YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Cisplatin; Cyclophosphamide; Pirarubicin; Salivary gland carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; PIRARUBICIN; RAMOSETRON;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; SALIVARY GLAND CARCINOMA; SIDE EFFECT; THROMBOCYTOPENIA; WEIGHT GAIN;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; SALIVARY GLAND NEOPLASMS;

EID: 33751103158     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480600818070     Document Type: Article

References (30)

1. Piechocki M, Lonardo F, Ensley JF, Nguyen T, Kim H, Yoo GH. Anticancer activity of docetaxel in murine salivary gland carcinoma. Clin Cancer Res 2002;8:870-7.
2. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg 1986;8: 177-84.
3. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg 1989;115:316-21.
4. Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg 1991;117:307-15.
5. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1990;18:1319-26.
6. Suen JY, Johns ME. Chemotherapy for salivary gland cancer. Laryngoscope 1982;92:235-9.
7. Kaplan JM, Johns ME, Cantrell RW. Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 1986;95: 165-70.
8. Venook AP, Tseng A Jr, Meyers FJ. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol 1987;5:951-5.
9. Dreyfuss AL, Clark JR, Fallon BG. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 1987; 60:2869-72.
10. Creagan ET, Woods JE, Schutt AJ. Cyclophosphamide, adriamycin, and cis-diamminedichloro-platinum (II) in the treatment of advanced nonsquamous cell head and neck cancer. Cancer 1983;52:2007-10.
11. Triozzi PL, Brantley A, Fisher S. 5-Fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer 1987;59:887-90.
12. Tsukuda M, Kokatsu T, Ito K, Mochimatsu I, Kubota A, Sawaki S. Chemotherapy for recurrent adeno- and adenoid-cystic carcinomas in the head and neck. J Cancer Res Clin Oncol 1993;119:756-8.
13. Tsukuda M, Mikami Y, Tanigaki Y, Katori H, Horiuchi C, Ikeda Y. Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck. Int J Clin Oncol 2004;9:161-6.
14. Katori H, Tsukuda M, Mochimatu I, Ishitoya J. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer 2004;90:348-52.
15. Katori H, Tsukuda M. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Clin Oncol 2005;17:148-52.
16. World Health Organization (WHO). Handbook for reporting results of cancer treatment. WHO offset publication no. 48. Geneva, Switzerland: World Health Organization; 1979.
17. Inuyama Y, Kida A, Tsukuda M. Late phase II study of S-1 in patients with advanced head and neck cancer. Jpn J Cancer Chemother 2001;28:1381-90.
18. Rentschler R, Burgess MA, Byers R. Chemotherapy of malignant major salivary gland neoplasms. A 25-year review of M.D. Anderson Hospital experience. Cancer 1977;40: 619-24.
19. Licitra L, Marchini S, Spinazze' S, Rossi A, Rocca A, Grandi C. Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients. Cancer 1991;68:1874-7.
20. Tannock IF, Sutherland DJ. Chemotherapy for adenoid cystic carcinoma. Cancer 1980;46:452-4.
21. Airoldi M, Brando V, Giordano C, Gabriele P, Bussi M, Cortesina G. Chemotherapy for recurrent salivary gland malignancies: experience of the ENT Department of Turin University. ORL J Otorhinolaryngol Relat Spec 1994;56: 105-11.
22. Posner MR, Ervin TJ, Weichselbaum RR. Chemotherapy of advanced salivary gland neoplasms. Cancer 1982;50:2261-4.
23. Alberts DS, Manning MR, Coulthard SW. Adriamycin/cisplatin/ cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland. Cancer 1981;47: 645-8.
24. Eisenberger MA. Supporting evidence for an active treatment program for advanced salivary gland carcinoma. Cancer Treat Rep 1985;69:319-21.
25. Creagan ET, Woods JE, Rubin J. Cisplatinbased chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck. Cancer 1988;62: 2313-9.
26. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma. Lancet 2000;355:949-55.
27. Bernier J, van Gladdeke M. Result of EORTIC phase III trial 22931 comparing, postoperatively, radiotherapy to concurrent chemo-radiotherapy with high dose cisplatin in locally advanced head and neck carcinomas. Eur J Cancer 2001; 37(Suppl 6):S267.
28. Cooper JS, Pajak TF, Forastiere AA. Postoperative concurrent radiochemotherapy in high risk SCCA of the head and neck: initial report of RTOG 9501/intergroup phase III trial. Proc Am Soc Clin Oncol 2002;21:226.
29. Taylor SG 4th, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994;12:385-95.
30. Airoldi M, Gabriele AM, Gabriele P, Pedani F, Marchionatti S, Succo G, et al. Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma. Tumori 2001;87:14-7.